A Study to Investigate the Bioavailability and Skin Absorption of CBD and THC From GT4 Technology in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 27, 2021

Primary Completion Date

January 18, 2022

Study Completion Date

January 18, 2022

Conditions
Biological AvailabilitySkin AbsorptionCBDTHC
Interventions
COMBINATION_PRODUCT

CBD and THC with GT4 technology

A single topical dose of CBD and THC will be administered with GT4 technology. The material will be provided in a single use pre-filled syringe.

Trial Locations (1)

Unknown

KGK Science Inc., London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

KGK Science Inc.

INDUSTRY

lead

Gefion Canada Inc.

OTHER